Critical Limb Ischemia - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Price : Single User: US $ 4950  US $ 4208 Corporate User: US $ 14850  US $ 10395
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Critical Limb Ischemia - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Critical Limb Ischemia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Critical Limb Ischemia till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Critical Limb Ischemia market.

  • Identifying patient populations in the global "Critical Limb Ischemiamarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Critical Limb Ischemia therapeutics in each of the markets covered.

  • To understand the future market competition in the global Critical Limb Ischemia therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Critical Limb Ischemia for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Critical Limb Ischemia - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Critical Limb Ischemia overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Critical Limb Ischemia Market
Global Epidemiology of Critical Limb Ischemia Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Critical Limb Ischemia Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Critical Limb Ischemia (2013-2023)
Table 7: Critical Limb Ischemia Global Market (USD Millions), (2013-2015)
Table 8: Critical Limb Ischemia Global Market (USD Millions), (2016-2023)
Table 9: Critical Limb Ischemia US Market (USD Millions), (2013-2015)
Table 10: Critical Limb Ischemia US Market (USD Millions), (2016-2023)
Table 11: Critical Limb Ischemia Germany Market (USD Millions), (2013-2015)
Table 12: Critical Limb Ischemia Germany Market (USD Millions), (2016-2023)
Table 13: Critical Limb Ischemia United Kingdom Market (USD Millions), (2013-2015)
Table 14: Critical Limb Ischemia United Kingdom Market (USD Millions), (2016-2023)
Table 15: Critical Limb Ischemia France Market (USD Millions), (2013-2015)
Table 16: Critical Limb Ischemia France Market (USD Millions), (2016-2023)
Table 17: Critical Limb Ischemia Italy Market (USD Millions), (2013-2015)
Table 18: Critical Limb Ischemia Italy Market (USD Millions), (2016-2023)
Table 19: Critical Limb Ischemia Spain Market (USD Millions), (2013-2015)
Table 20: Critical Limb Ischemia Spain Market (USD Millions), (2016-2023)
Table 21: Critical Limb Ischemia Japan Market (USD Millions), (2013-2015)
Table 22: Critical Limb Ischemia Japan Market (USD Millions), (2016-2023)
Table 23: Critical Limb Ischemia ROW Market (USD Millions), (2013-2015)
Table 24: Critical Limb Ischemia ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Critical Limb Ischemia Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Critical Limb Ischemia (2013-2023)
Figure 3: Critical Limb Ischemia Global Market (USD Millions), (2013-2015)
Figure 4: Critical Limb Ischemia Global Market (USD Millions), (2016-2023)
Figure 5: Critical Limb Ischemia US Market (USD Millions), (2013-2015)
Figure 6: Critical Limb Ischemia US Market (USD Millions), (2016-2023)
Figure 7: Critical Limb Ischemia Germany Market (USD Millions), (2013-2015)
Figure 8: Critical Limb Ischemia Germany Market (USD Millions), (2016-2023)
Figure 9: Critical Limb Ischemia United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Critical Limb Ischemia United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Critical Limb Ischemia France Market (USD Millions), (2013-2015)
Figure 12: Critical Limb Ischemia France Market (USD Millions), (2016-2023)
Figure 13: Critical Limb Ischemia Italy Market (USD Millions), (2013-2015)
Figure 14: Critical Limb Ischemia Italy Market (USD Millions), (2016-2023)
Figure 15: Critical Limb Ischemia Spain Market (USD Millions), (2013-2015)
Figure 16: Critical Limb Ischemia Spain Market (USD Millions), (2016-2023)
Figure 17: Critical Limb Ischemia Japan Market (USD Millions), (2013-2015)
Figure 18: Critical Limb Ischemia Japan Market (USD Millions), (2015-2023)
Figure 19: Critical Limb Ischemia ROW Market (USD Millions), (2013-2015)
Figure 20: Critical Limb Ischemia ROW Market (USD Millions), (2016-2023)

  • Myocardial Fibrosis - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 68
    Myocardial Fibrosis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Pipeline Review, H1 2017, provides an overview of the Myocardial Fibrosis (Cardiovascular) pipeline landscape. Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal swelling, nausea......
  • Myocardial Ischemia - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 64
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia - Pipeline Review, H1 2017, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape.Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of b......
  • Atherosclerosis - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 225
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Pipeline Review, H1 2017, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape.Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall. The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. Symptom......
  • Stroke - Pipeline Review, H1 2017
    Published: 23-May-2017        Price: US 2000 Onwards        Pages: 461
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H1 2017, provides an overview of the Stroke (Cardiovascular) pipeline landscape.Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They m......
  • Hypertrophic Cardiomyopathy - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H1 2017, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape.Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially during exercise, sensatio......
  • Critical Limb Ischemia - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 126
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia - Pipeline Review, H1 2017, provides an overview of the Critical Limb Ischemia (Cardiovascular) pipeline landscape.Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease (PAD). It is caused by chronic inflammatory processes associated with atherosclerosis that result in reduced blood flow to the legs, feet and hands. Symptoms include pain or numbness in feet ......
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 165
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2017, provides an overview of the Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) (Cardiovascular) pipeline landscape.Peripheral vascular disease (PVD) refers to diseases of the blood vessels (arteries and veins) located outside the heart and brain. Symptoms include painful cramping in hip, thigh or ca......
  • Ventricular Tachycardia - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 42
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Pipeline Review, H1 2017, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape.Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and heart failure. Risk fa......
  • Angina (Angina Pectoris) - Pipeline Review, H1 2017
    Published: 09-May-2017        Price: US 2000 Onwards        Pages: 67
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H1 2017, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs